Results 11 to 20 of about 6,963 (223)

Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease

open access: yesIDCases, 2016
A 7-year old boy developed myositis secondary to intramuscular injection of benzathine penicillin-G in the context of secondary prophylaxis for rheumatic heart disease.
Joshua R. Francis   +4 more
doaj   +1 more source

Laporan kasus berbasis bukti: Pemberian Benzathine Penicillin G Setiap 3 Minggu Dibandingkan 4 Minggu untuk Pencegahan Infeksi Streptokokus pada Anak dengan Penyakit Jantung Rematik

open access: yesSari Pediatri, 2022
Latar belakang. Infeksi Streptococcus yang memicu demam rematik dapat mendasari terjadinya penyakit jantung didapat pada anak. Demam rematik dapat dicegah baik dari pencegahan primordial, primer, dan sekunder.
Muhammad Yusra Firdaus   +1 more
doaj   +1 more source

Optimal antimicrobial duration for common bacterial infections [PDF]

open access: yes, 2019
Most antibiotic use in Australia arises from prescriptions in the community. The risk of antibiotic-related adverse events, including resistance, increases with longer treatment courses.
Daveson, Kathryn   +2 more
core   +1 more source

Safety and concerns of secondary prophylaxis for rheumatic heart disease with benzathine penicillin: A tertiary care cardiac centre experience

open access: yesJournal of Clinical and Preventive Cardiology, 2021
Background: Rheumatic Fever (RF) and Rheumatic heart disease (RHD) are common cardiovascular diseases in developing countries. Long-term Benzathine Penicillin G (BPG) injection is being used for secondary prophylaxis of RF/RHD.
Prabhavathi Bhat   +3 more
doaj   +1 more source

Quality of benzathine penicillin G: A multinational cross‐sectional study

open access: yesPharmacology Research & Perspectives, 2020
Benzathine penicillin G (BPG) is used as first‐line treatment for most forms of syphilis and as secondary prophylaxis against rheumatic heart disease (RHD).
Robert M. Hand   +12 more
doaj   +1 more source

Measuring antibiotic availability and use in 20 low- and middle-income countries [PDF]

open access: yes, 2020
Objective To assess antibiotic availability and use in health facilities in low- and middle-income countries, using the service provision assessment and service availability and readiness assessment surveys.
Hsia, Y   +6 more
core   +2 more sources

Availability of benzathine penicillin G for syphilis treatment in Shandong Province, Eastern China

open access: yesBMC Health Services Research, 2019
Background The shortage of benzathine penicillin G (BPG) worldwide presents a major challenge in the treatment of syphilis. Its availability for syphilis treatment has not been adequately evaluated in China.
Xinlong Chen   +4 more
doaj   +1 more source

Elimination of Congenital Syphilis in Ukraine: Analysis and the Emerging Issues [PDF]

open access: yes, 2017
The objective of this study is to analyze the indicators of the process of elimination of mother-to-child transmission of syphilis in Ukraine thus helping to prepare for elimination of this process according to the WHO targets and criteria ...
Derevyanko, L. (Lyudmyla)
core   +2 more sources

Jarisch‐Herxheimer reaction among HIV‐positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy

open access: yesJournal of the International AIDS Society, 2014
Introduction The Jarisch‐Herxheimer reaction, a febrile inflammatory reaction that often occurs after the first dose of chemotherapy in spirochetal diseases, may result in deleterious effects to patients with neurosyphilis and to pregnant women. A single
Mao‐Song Tsai   +12 more
doaj   +1 more source

Effectiveness of single-dose azithromycin to treat latent yaws: a longitudinal comparative cohort study [PDF]

open access: yes, 2017
BACKGROUND: Treatment of latent yaws is a crucial component of the WHO yaws eradication strategy to prevent relapse and the resulting transmission to uninfected children. We assessed the effectiveness of
Abel, Haina   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy